---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-007221"
form_type: "8-K"
ticker: "PROF"
cik: "0001628808"
company_name: "Profound Medical Corp."
filed_at: "2025-11-12T23:59:59+00:00"
generated_at: "2026-05-16T21:13:56.070442+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Profound Medical signs exclusive Saudi distribution deal for TULSA-PRO and Sonalleve with Al Faisaliah Medical Systems

## Summary
- Exclusive distribution and supply agreement for TULSA-PRO and Sonalleve in Saudi Arabia with Al Faisaliah Medical Systems Co.
- All regulatory approvals to import and sell the technologies in Saudi Arabia are already in place.
- Saudi Arabia is the largest healthcare market in the Middle East; deal expands Profound's presence.
- CEO Arun Menawat says FMS has a proven track record in introducing advanced medical technologies in the Kingdom.

## SEC filing metadata
- accession: 0001171843-25-007221
- form_type: 8-K
- ticker: PROF
- cik: 0001628808
- company_name: Profound Medical Corp.
- filed_at: 2025-11-12T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628808/000117184325007221/0001171843-25-007221-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628808/000117184325007221/f8k_111125.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-007221
- JSON: https://secwatch.observer/filing/0001171843-25-007221.json
- Plain text: https://secwatch.observer/filing/0001171843-25-007221.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.